New insights into early and late onset subgroups of preeclampsia from longitudinal versus cross-sectional analysis of urinary inositol-phosphoglycan P-Type

Arnaud Dominique L’omelette; Lalita Dawonauth; Laurens Rademacher; Pierre-Yves Robillard; Marco Scioscia; Sarojini Jankee; Man Yoon Lee Kwai Yan; Jeeawoody Razgia; Thomas W. Rademacher

New insights into early and late onset subgroups of preeclampsia from longitudinal versus cross-sectional analysis of urinary inositol-phosphoglycan P-Type

Arnaud Dominique L’omelette ^{1, *} Lalita Dawonauth ¹ Laurens Rademacher ² Pierre-Yves Robillard ^{3, 4} Marco Scioscia ⁵ Sarojini Jankee ¹ Man Yoon Lee Kwai Yan ¹ Jeeawoody Razgia ¹ Thomas W. Rademacher ^{6, 7}

* Corresponding author

1 University of Mauritius

2 Sylus Pharmaceuticals Ltd

3 CEPOI - Centre d'Études Périnatales de l'Océan Indien

4 CHU Sud Saint Pierre [Ile de la Réunion]

5 Hôpital Sacro Cuore, Negrar

6 University College London Medical School, University College London (UCL)

7 Middlesex University [London]

Abstract : Most pre-eclampsia (PE) studies have used cross-sectional data to derive conclusions regarding the pathophysiology of the condition. This has led to the concept that there exists early (<34 weeks) and late-onset (>34 weeks) disease according to gestational age at diagnosis. Survival time models have predicted that if the pregnancy was to continue indefinitely, all women would develop PE. In this study we have performed a longitudinal analysis of the urinary biomarker, inositol phosphoglycan (IPG), in a cohort of women giving birth in Mauritius (n-920). We have analysed the PE data in the traditional cross-sectional manner for n = 77 women who developed PE and also then looked at the longitudinal data for 71/77 of the same women. The data allows us to use longitudinal values to calculate a date of onset (first presence of biomarker in urine) and compare that to date of clinical diagnosis (cross sectional). We find two populations for both analysis consistent with an early and late stage subgroup. The calculated date of onset had subgroups (early and late) at 28.4 ± 0.41 weeks and 35.37 ± 0.26 weeks and for clinical date of diagnosis, 32.3 ± 0.59 weeks and 37.04 ± 0.62 weeks, respectively. The presence of the same biomarker in both subgroups and its ability to predict clinical onset 2–4 weeks prior to clinical diagnosis suggest that both groups may have similar aetiology.Urinary inositol phosphoglycan PPreeclampsia

Keywords : Urinary inositol phosphoglycan P Preeclampsia

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadatas

http://hal.univ-reunion.fr/hal-02021493
Contributor : Réunion Univ <>
Submitted on : Saturday, February 16, 2019 - 7:49:19 AM
Last modification on : Thursday, March 28, 2019 - 11:24:17 AM

New insights into early and late onset subgroups of preeclampsia from longitudinal versus cross-sectional analysis of urinary inositol-phosphoglycan P-Type

Identifiers

Collections

Citation

Export

Metrics

23

Contact

New insights into early and late onset subgroups of preeclampsia from longitudinal versus cross-sectional analysis of urinary inositol-phosphoglycan P-Type

Identifiers

Collections

Citation

Export

Share

Metrics

23

Contact